A detailed history of Public Employees Retirement System Of Ohio transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Public Employees Retirement System Of Ohio holds 367,373 shares of ESPR stock, worth $855,979. This represents 0.0% of its overall portfolio holdings.

Number of Shares
367,373
Holding current value
$855,979
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$1.61 - $2.73 $591,470 - $1 Million
367,373 New
367,373 $606,000
Q1 2023

Dec 19, 2023

BUY
$1.46 - $7.3 $160,299 - $801,496
109,794 Added 76.93%
252,516 $401,000
Q1 2023

May 15, 2023

BUY
$1.46 - $7.3 $160,299 - $801,496
109,794 Added 76.93%
252,516 $402,000
Q4 2022

Dec 19, 2023

BUY
$5.09 - $8.5 $726,454 - $1.21 Million
142,722 New
142,722 $889,000
Q4 2022

Feb 15, 2023

SELL
$5.09 - $8.5 $131,474 - $219,555
-25,830 Reduced 15.32%
142,722 $889,000
Q4 2021

Feb 15, 2022

BUY
$4.81 - $11.92 $544,559 - $1.35 Million
113,214 Added 204.59%
168,552 $843,000
Q4 2020

Feb 12, 2021

BUY
$24.2 - $35.76 $376,406 - $556,211
15,554 Added 39.1%
55,338 $1.44 Million
Q3 2020

Nov 16, 2020

BUY
$31.18 - $52.71 $631,301 - $1.07 Million
20,247 Added 103.63%
39,784 $1.48 Million
Q1 2020

May 13, 2020

BUY
$27.44 - $73.84 $26,973 - $72,584
983 Added 5.3%
19,537 $616,000
Q2 2019

Aug 12, 2019

SELL
$40.1 - $52.33 $71,378 - $93,147
-1,780 Reduced 8.75%
18,554 $863,000
Q3 2018

Nov 14, 2018

SELL
$40.74 - $51.41 $151,960 - $191,759
-3,730 Reduced 15.5%
20,334 $902,000
Q2 2018

Aug 22, 2018

SELL
$36.2 - $76.4 $193,597 - $408,587
-5,348 Reduced 18.18%
24,064 $943,000
Q1 2018

May 15, 2018

SELL
$65.94 - $80.76 $9,429 - $11,548
-143 Reduced 0.48%
29,412 $2.13 Million
Q2 2017

Aug 16, 2017

BUY
N/A
29,555
29,555 $1.37 Million

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $155M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.